InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by ARCH Venture Fund VIII, L.P.. Director active across 1 company, notably Codiak BioSciences, Inc.. Aggregated, 1 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €7.5m. History available since 13 September 2022. The latest transaction was filed on 13 September 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration